The use of Seraseq® Oncology controls & NGS validation challenges | Webinare | Technical Resources | HiSS Diagnostics
Intra-run performance using Seraseq Myeloid Mutation DNA run in... | Download Scientific Diagram
Frontiers | Why Single-Cell Sequencing Has Promise in MDS
AccuPlex™ SARS-CoV-2, Flu A/B and RSV Reference Material Kit | 0505-0174 | Seracare
Intra-run performance using Seraseq Myeloid Mutation DNA run in... | Download Scientific Diagram
Hematologic Malignancies, Myeloid | SeraCare
Clinical Validation of a Myeloid Next-Generation Sequencing Panel for Single-Nucleotide Variants, Insertions/Deletions, and Fusi
Reference Materials, Quality Control (QC) | SeraCare
Download this Scientific Poster: Development of Seraseq ctDNA
Hematologic Malignancies, Myeloid | SeraCare
SERASEQ® REFERENCE MATERIALS FOR NGS ONCOLOGY APPLICATIONS
Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panel | BMC Medical Genomics | Full Text
SERASEQ® REFERENCE MATERIALS FOR NGS ONCOLOGY APPLICATIONS
Seracare Life Sciences Inc SERASEQ MYELOID MUTATION DNA, Quantity: Each | Fisher Scientific
SERASEQ® REFERENCE MATERIALS FOR NGS ONCOLOGY APPLICATIONS
Seraseq® Myeloid Mutation DNA Mix 1 x 25 µL
Seracare Life Sciences Inc SERASEQ MYELOID MUTATION DNA, Quantity: Each | Fisher Scientific
SERASEQ® REFERENCE MATERIALS FOR NGS ONCOLOGY APPLICATIONS
Articles about SeraCare Life Sciences, Inc.
The First Comprehensive Myeloid Cancer Reference Materials for NGS Assays
Seraseq® Myeloid Reference Materials: DNA, RNA Fusion, ctDNA
